Endovascular Embolization as a Stand-Alone Treatment of Head and Neck Paragangliomas with Long-Term Tumor Control

References

1. 1.↵
   1. Sandow L,
   2. Thawani R,
   3. Kim MS, et al

   . Paraganglioma of the head and neck: a review. Endocr Pract 2023;29:141–47 doi:10.1016/j.eprac.2022.10.002 pmid:36252779

   CrossRefPubMed
2. 2.↵
   1. Langerman A,
   2. Athavale SM,
   3. Rangarajan SV, et al

   . Natural history of cervical paragangliomas: outcomes of observation of 43 patients. Arch Otolaryngol Head Neck Surg 2012;138:341–45 doi:10.1001/archoto.2012.37 pmid:22431860

   CrossRefPubMed
3. 3.↵
   1. Jansen JC,
   2. van den Berg R,
   3. Kuiper A, et al

   . Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer 2000;88:2811–16 doi:10.1002/1097-0142(20000615)88:12<2811::AID-CNCR21>3.0.CO;2-7

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Tamaki A,
   2. Nyirjesy S,
   3. Cabrera CI, et al

   . Treatment decision and estimation of growth of head and neck paragangliomas. Am J Otolaryngol 2022;43:103357 doi:10.1016/j.amjoto.2021.103357 pmid:34972002

   CrossRefPubMed
5. 5.↵
   1. Graham NJ,
   2. Smith JD,
   3. Else T, et al

   . Paragangliomas of the head and neck: a contemporary review. Endocr Oncol 2022;2:R153–62 doi:10.1530/EO-22-0080 pmid:37435464

   CrossRefPubMed
6. 6.↵
   1. Valero C,
   2. Ganly I

   . Paragangliomas of the head and neck. J Oral Pathol Med 2022;51:897–903 doi:10.1111/jop.13286 pmid:35178777

   CrossRefPubMed
7. 7.↵
   1. Offergeld C,
   2. Brase C,
   3. Yaremchuk S, et al

   . Head and neck paragangliomas: clinical and molecular genetic classification. Clinics (Sao Paulo) 2012;67 Suppl 1:19–28 doi:10.6061/clinics/2012(sup01)05 pmid:22584701

   CrossRefPubMed
8. 8.↵
   1. Gilbo P,
   2. Morris CG,
   3. Amdur RJ, et al

   . Radiotherapy for benign head and neck paragangliomas: a 45-year experience. Cancer 2014;120:3738–43 doi:10.1002/cncr.28923 pmid:25060724

   CrossRefPubMed
9. 9.↵
   1. Liu J,
   2. Li Y,
   3. Yang L, et al

   . Surgical resection of carotid body tumors with versus without preoperative embolization: retrospective case-control study. Head Neck 2018;40:2590–95 doi:10.1002/hed.25387 pmid:30387536

   CrossRefPubMed
10. 10.↵
    1. Wu Z,
    2. Qiu P,
    3. Pu H, et al

    . Efficacy and safety of preoperative embolization in carotid body tumor treatment: a propensity score matching retrospective cohort study. Head Neck 2022;44:1414–21 doi:10.1002/hed.27038 pmid:35319144

    CrossRefPubMed
11. 11.↵
    1. Makeieff M,
    2. Thariat J,
    3. Reyt E, et al

    . Treatment of cervical paragangliomas. Eur Ann Otorhinolaryngol Head Neck Dis 2012;129:308–14 doi:10.1016/j.anorl.2012.03.006 pmid:23021979

    CrossRefPubMed
12. 12.↵
    1. Arya S,
    2. Rao V,
    3. Juvekar S, et al

    . Carotid body tumors: objective criteria to predict the Shamblin group on MR imaging. AJNR Am J Neuroradiol 2008;29:1349–54 doi:10.3174/ajnr.A1092 pmid:18417602

    Abstract/FREE Full Text
13. 13.↵
    1. Luna-Ortiz K,
    2. Rascon-Ortiz M,
    3. Villavicencio-Valencia V, et al

    . Does Shamblin’s classification predict postoperative morbidity in carotid body tumors? A proposal to modify Shamblin’s classification. Eur Arch Otorhinolaryngol 2006;263:171–75 doi:10.1007/s00405-005-0968-4 pmid:16010570

    CrossRefPubMed
14. 14.↵
    1. Chen PG,
    2. Nguyen JH,
    3. Payne SC, et al

    . Treatment of glomus jugulare tumors with gamma knife radiosurgery. Laryngoscope 2010;120:1856–62 doi:10.1002/lary.21073 pmid:20623790

    CrossRefPubMed
15. 15.↵
    1. Patel NS,
    2. Carlson ML,
    3. Pollock BE, et al

    . Long-term tumor control following stereotactic radiosurgery for jugular paraganglioma using 3D volumetric segmentation. J Neurosurg 2018;130:379–87 doi:10.3171/2017.10.JNS17764 pmid:29652232

    CrossRefPubMed
16. 16.↵
    1. Campbell JC,
    2. Lee JW,
    3. Ledbetter L, et al

    . Systematic review and meta-analysis for surgery versus stereotactic radiosurgery for jugular paragangliomas. Otol Neurotol 2023;44:195–200 doi:10.1097/MAO.0000000000003781 pmid:36728610

    CrossRefPubMed
17. 17.↵
    1. Dharnipragada R,
    2. Butterfield JT,
    3. Dhawan S, et al

    . Modern management of complex tympanojugular paragangliomas: systematic review and meta-analysis. World Neurosurg 2023;170:149–56.e3 doi:10.1016/j.wneu.2022.11.037 pmid:36400356

    CrossRefPubMed
18. 18.↵
    1. Fatima N,
    2. Pollom E,
    3. Soltys S, et al

    . Stereotactic radiosurgery for head and neck paragangliomas: a systematic review and meta-analysis. Neurosurg Rev 2021;44:741–52 doi:10.1007/s10143-020-01292-5 pmid:32318920

    CrossRefPubMed
19. 19.↵
    1. Anderson JL,
    2. Khattab MH,
    3. Anderson C, et al

    . Long-term outcomes for the treatment of paragangliomas in the upfront, adjuvant, and salvage settings with stereotactic radiosurgery and intensity-modulated radiotherapy. Otol Neurotol 2020;41:133–40 doi:10.1097/MAO.0000000000002461 pmid:31789966

    CrossRefPubMed
20. 20.↵
    1. Liscak R,
    2. Urgosik D,
    3. Chytka T, et al

    . Leksell gamma knife radiosurgery of the jugulotympanic glomus tumor: long-term results. J Neurosurg 2014;121:Suppl 198–202
21. 21.↵
    1. Weissmann T,
    2. Lettmaier S,
    3. Roesch J, et al

    . Paragangliomas of the head and neck: local control and functional outcome following fractionated stereotactic radiotherapy. Am J Clin Oncol 2019;42:818–23 doi:10.1097/COC.0000000000000614 pmid:31592806

    CrossRefPubMed
22. 22.↵
    1. Schartz D,
    2. Manganaro M,
    3. Szekeres D, et al

    . Direct percutaneous puncture versus transarterial embolization for head and neck paragangliomas: a systematic review and meta-analysis. Interv Neuroradiol 2023: 15910199231188859. doi:10.1177/15910199231188859 pmid:37455341

    CrossRefPubMed
23. 23.↵
    1. White JB,
    2. Link MJ,
    3. Cloft HJ

    . Endovascular embolization of paragangliomas: a safe adjuvant to treatment. J Vasc Interv Neurol 2008;1:37–41 pmid:22518217

    PubMed
24. 24.↵
    1. Griauzde J,
    2. Gemmete JJ,
    3. Chaudhary N, et al

    . A comparison of particulate and Onyx embolization in preoperative devascularization of carotid body tumors. Neuroradiology 2013;55:1113–18 doi:10.1007/s00234-013-1220-3 pmid:23793907

    CrossRefPubMed
25. 25.↵
    1. Helal A,
    2. Vakharia K,
    3. Brinjikji W, et al

    . Preoperative embolization of jugular paraganglioma tumors using particles is safe and effective. Interv Neuroradiol 2022;28:145–51 doi:10.1177/15910199211019175 pmid:34034540

    CrossRefPubMed
26. 26.↵
    1. De Marini P,
    2. Greget M,
    3. Boatta E, et al

    . Safety and technical efficacy of pre-operative embolization of head and neck paragangliomas: a 10-year mono-centric experience and systematic review. Clin Imaging 2021;80:292–99 doi:10.1016/j.clinimag.2021.08.014

    CrossRef
27. 27.↵
    1. Kocur D,
    2. Ślusarczyk W,
    3. Przybyłko N, et al

    . Endovascular approach to glomus jugulare tumors. Pol J Radiol 2017;82:322–26 doi:10.12659/PJR.901141 pmid:28685005

    CrossRefPubMed
28. 28.↵
    1. Tasar M,
    2. Yetiser S

    . Glomus tumors: therapeutic role of selective embolization. J Craniofac Surg 2004;15:497–505 doi:10.1097/00001665-200405000-00031 pmid:15111818

    CrossRefPubMed
29. 29.↵
    1. Michelozzi C,
    2. Januel AC,
    3. Cuvinciuc V, et al

    . Arterial embolization with Onyx of head and neck paragangliomas. J Neurointerv Surg 2016;8:626–35 doi:10.1136/neurintsurg-2014-011582 pmid:25935924

    Abstract/FREE Full Text
30. 30.↵
    1. Iaccarino V,
    2. Sodano A,
    3. Belfiore G, et al

    . Embolization of glomus tumors of the carotid: temporary or definitive? Cardiovasc Intervent Radiol 1985;8:206–10 doi:10.1007/BF02552901 pmid:2416442

    CrossRefPubMed